Lesley Seymour

机构：Canadian Cancer Society, Queen's University, Canadian Partnership Against Cancer, Canadian Cancer Trials Group · ORCID：0000-0001-8081-0799

发表论文 377 篇 · 总被引 35977 次 · h-index 76

代表论文

Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group (2024 · Clinical Cancer Research · 被引 33)
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable (2024 · EClinicalMedicine · 被引 23)
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials (2025 · Journal of Clinical Oncology · 被引 14)
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer (2024 · Clinical Cancer Research · 被引 9)
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials (2025 · EClinicalMedicine · 被引 5)
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols (2025 · EClinicalMedicine · 被引 3)